The beverage landscape is undergoing a radical transformation as consumers increasingly prioritize function over flavour. What began as a niche market for health-conscious buyers has exploded into a global phenomenon, with analysts projecting the functional beverage sector could reach a staggering $618.8 billion by 2034. This seismic shift represents more than just changing consumer preferences—it signals a fundamental reimagining of what beverages can and should do for our health and well-being.

The New Era of Purpose-Driven Drinking

Today’s consumers no longer view beverages simply as thirst-quenchers or indulgent treats. Modern shoppers, particularly millennials and Gen Z, are demanding drinks that deliver measurable health benefits alongside refreshment. This paradigm shift is being driven by several powerful forces converging simultaneously: an aging population seeking preventative health solutions, time-pressed consumers wanting nutrition on the go, and a growing distrust of traditional pharmaceuticals pushing people toward natural alternatives.

Research and Markets forecasts the global functional beverage market will reach $175 billion by 2030, while Insightace Analytic presents an even more bullish projection of $618.8 billion by 2034. This explosive growth is being led by women consumers and Asia-Pacific markets, where clean-label products, plant-based ingredients, and scientifically validated benefits are becoming purchase prerequisites rather than nice-to-have features.

The Science of Functional Beverages

At the core of this revolution is a new generation of beverages engineered to deliver specific health outcomes. Unlike their vitamin-enhanced predecessors, today’s functional drinks utilize cutting-edge nutritional science to target precise physiological needs. The most sought-after benefits currently driving innovation include cognitive enhancement through nootropics, gut health optimization via advanced probiotic strains, stress reduction using adaptogenic herbs, and alcohol metabolism support—a particularly promising category that has seen remarkable scientific advancement in recent years.

Safety Shot (NASDAQ: SHOT) has emerged as a pioneer in this latter category with its clinically validated formula shown to reduce blood alcohol content. Published research in the Journal of Nutrition and Dietary Supplements demonstrates the drink’s ability to not only lower BAC but also improve next-day alertness—a combination that addresses both immediate and next-morning concerns for social drinkers.

From Lab to Shelf: The Functional Beverage Market Matures

The functional beverage sector is rapidly evolving from scattered niche products to a sophisticated, science-driven industry. Safety Shot’s trajectory exemplifies this maturation, having expanded from direct-to-consumer sales to nationwide retail distribution in under a year. The drink is now available through major retailers including 7-Eleven, Albertsons, and Vons, as well as e-commerce platforms like Amazon and Walmart.com.

This retail expansion has been accompanied by product innovation, including the recent introduction of a stick-pack format designed for convenience and trial. The company’s strategic acquisition of Yerbaé Brands further demonstrates the industry’s consolidation trend, combining complementary functional beverage lines to create a more robust product portfolio.

The Future of Functional: Where the Industry is Headed

Looking ahead, several key trends are poised to shape the next chapter of functional beverages. Personalization is emerging as a major frontier, with AI-driven formulations that can be tailored to individual health needs and genetic profiles. The alcohol alternative space continues to expand, catering to both sober-curious consumers and those seeking healthier ways to socialize. Perhaps most significantly, we’re seeing the lines blur between beverages, supplements, and even pharmaceuticals as functional drinks incorporate increasingly sophisticated active ingredients.

For investors and industry watchers, the functional beverage revolution represents one of the most dynamic opportunities in consumer goods today. As Safety Shot and other innovators continue to push boundaries, they’re not just creating new products—they’re redefining the very role beverages play in our daily health routines.

Stay ahead of the trends with IHRMAGAZINE.com—your source for cutting-edge insights on the future of food, beverage, and wellness innovation.

Every nation at the forefront of medical progress depends on comprehensive population health studies to unlock discoveries that shape better healthcare. For Canada, that essential resource is CanPath (the Canadian Partnership for Tomorrow’s Health), the country’s most extensive long-term health research initiative. With data from over 330,000 participants—nearly one in every hundred Canadians—CanPath examines how genetics, lifestyle, and environmental factors influence chronic diseases and cancer, offering insights that could transform prevention and treatment nationwide.

Foundations of a National Health Legacy

Born from the 2006 Canadian Strategy for Cancer Control, CanPath has grown into a collaborative network encompassing seven regional cohorts from coast to coast, including the BC Generations Project, Alberta’s Tomorrow Project, and the Atlantic Partnership for Tomorrow’s Health. For nearly two decades, this initiative has enabled critical research into cancer, chronic illness, and health disparities, thanks to the dedication of Canadians who have shared their health data for the greater good.

Yet despite its achievements, CanPath’s future is uncertain. Declining operational funding jeopardizes Canada’s ability to leverage this world-class dataset, putting the country at risk of falling behind in global health innovation.

The Critical Role of CanPath in Modern Health Research

Recent public health emergencies have underscored the importance of real-time, large-scale health data. CanPath’s contributions have been vital in tracking emerging health risks, identifying at-risk populations, and guiding policy responses. According to Dr. Fei-Fei Liu, Scientific Director at the Canadian Institutes of Health Research, “Deep, well-established cohorts like CanPath don’t just advance science—they save lives and reduce healthcare costs by enabling early intervention and prevention.”

Beyond cancer research, CanPath has expanded into environmental health and social determinants of well-being. A partnership with the Canadian Urban Environmental Health Research Consortium (CANUE) has enriched the platform with 17 new datasets on air quality, green spaces, and community health factors—aligning with Bill S-5’s recognition of every Canadian’s right to a healthy environment.

Strengthening Research Through Strategic Partnerships

Collaboration is key to CanPath’s success. A landmark agreement with the Canadian Institute for Health Information (CIHI) now integrates anonymized records on hospital visits, emergency care, and long-term stays with CanPath’s wealth of genetic and lifestyle data. This fusion creates unprecedented opportunities to study health trends and improve care delivery.

At the same time, CanPath is pioneering next-generation data security and accessibility with a cloud-based research platform that allows scientists to analyze sensitive health information without compromising privacy. This innovation opens doors for biotech advancements, precision medicine, and public-private research partnerships that could position Canada as a leader in health innovation.

A Call to Safeguard Canada’s Health Research Leadership

The Canadians who participate in CanPath do so with the belief that their data will drive meaningful change. Dr. Christine Williams of the Ontario Institute for Cancer Research emphasizes this trust, stating, “We owe it to these individuals—and to future generations—to ensure their contributions lead to lasting impact.”

But without stable, long-term funding, CanPath’s potential remains untapped. In an era where data shapes health policy and medical breakthroughs, Canada cannot afford to lose this vital resource. Investing in CanPath means investing in a stronger, more resilient healthcare system—one where diseases are detected earlier, treatments are more precise, and public health strategies are rooted in evidence.

The choice is clear: Canada either commits to sustaining its premier health research platform or risks surrendering its place at the forefront of global medical progress.

For more on health policy and innovation, visit IHR Magazine.

When Ottawa’s Fullscript first opened its doors in 2011, its founders had a simple yet ambitious vision: to bridge the gap between clinicians and patients by seamlessly integrating evidence-based supplement prescribing, advanced lab testing and adherence tools into everyday practice. Fast-forward to 2025, and that vision has drawn renewed backing from HGGC, Snapdragon Capital Partners and Leonard Green & Partners—an endorsement that bodes well for Canada’s burgeoning digital health sector.

A New Infusion of Confidence

The announcement landed in mid-May: HGGC and Snapdragon deepening their stakes in Fullscript, supported by a continuation vehicle led by Leonard Green & Partners. For investors who first came aboard in 2021, the deal isn’t just a moment to celebrate returns—it’s a signal that Fullscript’s patient-centred model remains ahead of the pack. “This investment allows us to continue advancing our technology, expanding our services, and empowering more practitioners to deliver personalized, proactive care,” says Fullscript co-founder and CEO Kyle Braatz.

From Start-Up to Scale-Up

Fullscript’s growth story is one of measured ambition. From its early days helping boutique naturopathic clinics place supplement orders, the platform now supports more than 100,000 providers and 10 million patients across North America. Its lab’s network—integrated directly into clinic workflows—has transformed what once was a fragmented process of bloodwork orders, sample tracking and follow-up into a single, clinician-friendly interface.

Yet what sets Fullscript apart is its focus on long-term outcomes. Through its patient adherence app, individuals can track their supplement routines, receive gentle reminders and access educational content curated by their practitioners. The result? Higher adherence rates, better health outcomes, and a reinforcing cycle of trust between patient and provider.

Powering Preventive Health in Canada

In Canada, where wait times and rising healthcare costs dominate headlines, Fullscript’s preventive ethos strikes a compelling chord. Dietitians, chiropractors and integrative physicians alike are embracing the platform to prescribe targeted nutritional interventions that can help stave off chronic conditions—often before they require more intensive medical treatments. Fullscript’s Ottawa-based team has grown in tandem, with plans to expand its local customer-support centre and deepen partnerships with Canadian labs and distributors to cut delivery times even further.

Aligning Investors and Innovators

For HGGC—managing over US$8 billion in commitments—the renewed investment fits squarely within a portfolio that prizes technology-driven health and wellness companies. Snapdragon Capital Partners, whose consumer-focused growth strategy has driven successes in franchising and B2B2C services, likewise sees Fullscript as emblematic of next-generation care delivery. Leonard Green & Partners’ continuation vehicle offered a dual benefit: it allowed earlier backers to realize some liquidity, while infusing fresh growth capital and ensuring all stakeholders remained aligned on Fullscript’s trajectory.

“This transaction reflects our conviction in Fullscript’s long-term value creation potential,” explains Mark Grabowski, Founder and Managing Partner at Snapdragon. David Fox and Garrett Hall, co-heads of LGP’s Sage strategy, add that they look forward to supporting Fullscript’s evolution as a market leader with “strong competitive positions and sustainable growth.”

What Lies Ahead

Armed with this new round of financing, Fullscript has its sights set on several strategic priorities: enhancing its machine-learning capabilities to deliver ever-more tailored supplement recommendations; rolling out richer analytics dashboards for clinicians; and exploring opportunities to extend its preventive-care toolkit into adjacent markets.

For Canadian practitioners and their patients, the upside is clear: faster access to reliable lab services, deeper insights into treatment effectiveness and more engaging tools to keep health goals front and centre. And for Fullscript—a once-young disruptor now entering its teenage years—this fresh infusion of confidence may be the catalyst that propels whole-person care into the mainstream.

Photo: Exterior of Pharmavite’s new 225,000 sq ft manufacturing and R&D centre in New Albany, Ohio.

New Albany, Ohio – Pharmavite LLC, the U.S.-based maker of Nature Made® vitamins, has officially opened its newest manufacturing and research & development facility in New Albany, signalling a significant expansion of its vitamin gummy production and innovation capabilities. The 225,000 sq ft site represents a US $250 million investment—Pharmavite’s first in Central Ohio—and is forecast to create 225 new jobs, with room for further growth on the adjacent property.

A Strategic Choice for Growth
“Our decision to locate in New Albany followed an exhaustive site-selection process,” says Pharmavite CEO Jeff Boutelle. “We’re proud to join this emerging hub of science, innovation and technology and to be embraced by a community that prioritizes wellness.” Since breaking ground in 2023, Pharmavite has collaborated with JobsOhio, One Columbus and the City of New Albany to ensure the facility aligns with regional economic and health-focused objectives.

Boosting Vitamin Gummies Production
Vitamin gummies have surged in popularity, nearly doubling in market size since 2019, with Nature Made leading in dollar-growth for the category in 2024. The New Albany plant will house two dedicated gummy production lines, warehouses and state-of-the-art laboratories, enhancing output and quality control for both Nature Made and Pharmavite’s other brands, including MegaFood®.

Gummies Innovation Centre of Excellence
A hallmark of the new site is the Gummies Innovation Centre of Excellence, where product development and scientific research will be co-located. This integrated approach seeks to accelerate formulation cycles and optimize nutrient stability in chewable formats, a critical factor as consumers increasingly seek convenient, science-backed supplements. “Bringing R&D under one roof allows for more agile innovation and faster consumer access to cutting-edge products,” explains Ray Gosselin, Pharmavite EVP and COO.

Beyond manufacturing, Pharmavite has committed to being an active community partner, supporting local initiatives such as Pelotonia, Healthy New Albany and the Mid-Ohio Food Collective. “This investment is more than bricks and mortar; it’s a long-term pledge to Central Ohio’s prosperity and well-being,” adds Boutelle. New Albany Mayor Sloan Spalding notes that Pharmavite’s arrival bolsters the city’s Health and Life Sciences cluster, reinforcing its reputation as a leading business park.

Zevia PBC (NYSE: ZVIA), the maker of naturally sweetened, zero-sugar beverages, delivered first-quarter results that landed at the upper end of guidance and showcased margin improvements despite a modest revenue dip. Net sales came in at US $38.0 million, down 2 percent from US $38.8 million in Q1 2024, reflecting heightened promotional activity even as pricing actions and a small volume uptick partially offset channel disruptions Nasdaq.

Strong Margin Performance
Gross profit margin climbed to a record 50.1 percent, a 4.4-point year-over-year gain driven by lower product costs and more efficient inventory management, partially tempered by increased trade spend Nasdaq. This marks the highest quarterly margin in Zevia’s public-company history and underscores the early benefits of its Productivity Initiative, which also fuelled a 25.8 percent reduction in selling expenses as a percentage of sales Nasdaq.

Improved Profitability Metrics
Zevia narrowed its net loss to US $6.4 million (US $0.08 per share), down from US $7.2 million (US $0.10 per share) in the year-ago quarter. Non-GAAP adjusted EBITDA loss improved by US 2.2 million to US 3.3 million, outperforming the company’s own forecast of a US 5.6 million to US 6.0 million loss, largely thanks to stronger-than-anticipated margin expansion Nasdaq.

Operational Investments and Cost Savings
Selling and marketing outlays rose to US $15.3 million (40.3 percent of net sales), primarily reflecting a US 3.5 million increase in marketing spend aimed at bolstering brand awareness through new campaign activations and innovation support. Conversely, direct selling costs fell significantly, fueled by freight and warehousing efficiencies achieved under the Productivity Initiative. General and administrative expenses declined to US $7.0 million, or 18.4 percent of sales, down from 20.9 percent in Q1 2024 Nasdaq.

Market Reaction and Analyst Commentary
Zevia’s earnings beat consensus forecasts, with adjusted EPS of –US $0.08 surpassing the –US $0.10 estimate by roughly 20 percent; some analysts noted this represented a 31 percent upside to street expectations Yahoo Finance. Despite the modest sales contraction—below analyst revenue forecasts of approximately US $40.8 million—the stock saw a positive reaction, buoyed by confidence in Zevia’s path to profitability and sufficient liquidity, as the company held US $27.7 million in cash with no debt and an unused US $20 million credit line at quarter-end Nasdaq.

Maintained 2025 Outlook
Management reaffirmed full-year guidance, expecting net sales between US $158 million and US $163 million and an adjusted EBITDA loss of US $8 million to US $11 million. The second-quarter outlook calls for US $40.5 million to US $42.5 million in net sales and an adjusted EBITDA loss of US $2.2 million to US $2.9 million Nasdaq. Zevia emphasizes reinvestment of productivity gains into marketing and innovation, alongside distribution expansion to deepen penetration in both core and emerging retail channels.

With record margins underscoring the efficacy of its cost-management programmes and a sharpened focus on brand building and product pipeline expansion, Zevia is positioning itself to capitalize on growing consumer demand for clean-label, zero-sugar beverages. As it navigates the balance between promotional intensity and profitability, industry observers will be watching for sustained volume growth and further margin optimization through the remainder of 2025.

Latin America is home to a rich and varied culinary landscape, yet it also faces significant challenges in ensuring food safety across restaurants, hotels, cafés and convenience outlets. In response to growing consumer concerns, NSF International—an independent global public health and safety organization headquartered in Ann Arbor, Michigan—has rolled out its Checked by NSF™ seal across Latin America, providing a transparent, third-party verification of food safety and hygiene practices.

Each year, unsafe food accounts for an estimated 600 million cases of foodborne illness and 420 000 deaths worldwide, according to the World Health Organization. That equates to nearly one in ten people falling ill from contaminated food, with children under five particularly vulnerable, accounting for roughly 30 percent of these fatalities. Such statistics underscore the critical need for reliable indicators that consumers can trust when choosing where to dine or purchase prepared foods. World Health OrganizationWorld Health Organization

Bridging the Transparency Gap

Traditionally, finding credible food-safety information about a given establishment can be cumbersome for Latin American consumers. While some jurisdictions publish inspection reports, the data may be outdated or hard to access. The Checked by NSF mark addresses this gap by signalling, at a glance, that an independent audit was conducted on a specific date, and that the venue meets rigorous hygiene and handling standards derived from the U.S. FDA Food Code 2022, adapted to align with local regulations.

“Displaying the Checked by NSF seal, whether on-site or online, represents a competitive advantage for food service operators,” explains Ronald Gonzalez, Director of NSF’s Food Services division for Latin America. “It demonstrates an establishment’s commitment to consumer safety and elevates confidence in brand quality, setting certified venues apart from their peers.”

A Three-Phase Verification Process

The Checked by NSF certification unfolds in three distinct stages:

1. Policy Review
   NSF experts examine the business’s existing food-safety and hygiene policies, ensuring they meet the standards specified by both the FDA Food Code and applicable local laws.
2. On-Site Facility Audit
   Trained auditors visit the premises to verify that written policies are properly implemented in practice. They inspect food handling, storage, preparation areas and overall facility cleanliness.
3. Routine Monitoring
   To maintain integrity, NSF conducts follow-up visits at frequencies determined by risk factors and local requirements, confirming ongoing compliance with hygiene and safety protocols.

Impact on the Foodservice Industry

By offering a clear, recognizable seal of approval, Checked by NSF empowers consumers to make informed choices and fosters a culture of accountability among food operators. For multi-unit chains and independent establishments alike, the programme can drive operational improvements, reducing the risk of foodborne incidents, minimizing reputational damage, and potentially lowering insurance premiums.

Moreover, this initiative aligns with broader One Health and Global Food Safety efforts, which emphasize the interconnectedness of human, animal and environmental health. Transparent certification schemes like Checked by NSF complement public-sector inspection regimes, reinforcing best practices at every step of the food chain.

Looking Ahead

NSF International plans to expand the programme’s reach across major urban centres in Latin America over the coming year, targeting high-traffic hospitality and retail outlets. As demand for reliable food-safety assurances grows, hotels, restaurants and food-service chains that adopt Checked by NSF early will be well-positioned to capture discerning customers and demonstrate leadership in public health stewardship.

In a region where culinary tradition is a point of pride, Checked by NSF offers both consumers and businesses a simple yet powerful tool: a seal that speaks volumes about safety, quality and trust. By raising the bar for hygiene transparency, NSF’s latest programme represents a meaningful step toward safer, more resilient food systems throughout Latin America.

In the first quarter of fiscal 2026, Walmart Inc. reported revenue of US $165.6 billion, a 2.5% increase year over year and a 4.0% gain on a constant-currency basis. This growth occurred despite a roughly 100-basis-point headwind from last year’s leap day. Operating income rose by US $0.3 billion, or 4.3% year over year (3.0% on a constant-currency basis), reflecting higher gross margins and stronger performance in membership and digital channels.

Revenue Drivers and Currency Impact
Walmart overcame the leap-year timing issue through resilient demand for its core everyday-low-price offerings and continued international expansion. Excluding currency effects, sales climbed 4.0%, while the reported 2.5% increase reflected a 100-basis-point negative impact from currency translation.

eCommerce and Fulfillment Advances
Global eCommerce revenue grew by 22%, led by expanded store-fulfilled pickup and delivery services and an increased contribution from the online marketplace. These gains underscore Walmart’s progress in integrating its physical store network with its digital operations.

Advertising and Membership Income
The company’s advertising division, Walmart Connect, recorded a 50% rise in global revenue, driven in part by its partnership with VIZIO; U.S. advertising revenues increased 31%. Membership and other non-merchandise income rose 3.7%, including a 14.8% increase in membership fees. Together, these higher-margin businesses helped diversify Walmart’s revenue streams.

Margin Improvement and Profitability Metrics
Walmart U.S. gross margins improved by 12 basis points as the company enhanced cost efficiencies. Operating income increased 4.3% (3.0% adjusted for currency), despite a 250-basis-point leap-year comparability headwind. Return on assets reached 7.5%, and return on invested capital rose to 15.3%, a 30-basis-point improvement.

Earnings and Capital Actions
GAAP earnings per share (EPS) were US $0.56, while adjusted EPS was US $0.61 after excluding a net US $0.05 loss on equity and other investments. During the quarter, Walmart issued US $4 billion in long-term debt at favourable rates to support general corporate initiatives, reflecting its strong credit profile.

Outlook and Guidance
Walmart provided guidance for the second quarter and reaffirmed its full-year FY 26 targets. The company expects net sales to grow 3%–4% and adjusted operating income to increase 3.5%–5.5% on a constant-currency basis, assumptions that include approximately 150 basis points of leap-year comparability headwinds and the impact of the VIZIO acquisition. Management held a conference call on May 15, 2025, to review these results and projections.

Overall, Walmart’s Q1 results reflected a balanced mix of stable core retail performance, rapid digital growth, and expanding higher-margin services, positioning the company to meet its full-year objectives.

TORONTO, May 2025 – This month, Nature’s Source celebrates its 27th anniversary, reflecting on a quarter-century of steady growth and unwavering commitment to natural health. What began in 1998 as a single dispensary in the Greater Toronto Area has evolved into a 17-store network—branded as Nature’s Source and Nature’s Signature—with an e-commerce platform serving customers across Canada and the U.S.

From Humble Beginnings to National Footprint

Founded by naturopathy enthusiast Sanjiv Jagota in Oakville, Ont., Nature’s Source opened its doors with a simple mission: “to inspire natural, healthy living.” In the years since, the company has expanded to 11 standalone stores and six in-grocery dispensaries within Metro locations, making quality supplements and expert advice more accessible to Canadians. Last summer, the brand marked a milestone with its 17th location, nestled in north Whitby, Ont.

Award-Winning Expertise and Professional Partnerships

Nature’s Source’s dedication to service has been recognized by industry peers. The company is a recipient of the Brock Elliot Award—the highest accolade in Canadian natural health retail—for excellence in product quality and customer education. Its expert staff are trained in naturopathy, homeopathy and nutrition, and the brand maintains close ties with the Ontario Association of Naturopathic Doctors (OAND) and the Canadian Health Food Association (CHFA).

“Our customers trust us to guide their wellness journeys,” says Jagota. “Reaching 27 years is a testament not only to our team’s passion but to the growing demand for natural, evidence-based health solutions.”

Embracing Digital and Community Engagement

Beyond bricks-and-mortar growth, Nature’s Source has invested heavily in its digital presence. Its online store offers nationwide shipping, live chat support and a comprehensive resource centre featuring expert-led webinars and articles. Locally, each store hosts workshops and product demonstrations led by certified practitioners, strengthening ties with community partners and health-focused organizations.

Looking Ahead: Innovation and Accessibility

As it enters its 28th year, Nature’s Source plans to broaden its product portfolio with cutting-edge nutraceuticals and expand Nature’s Signature kiosks into new grocery partners. Continued investment in digital tools—such as personalized supplement recommendations—aims to streamline the customer experience.

“We’re poised for further growth,” Jagota adds. “Our focus remains on empowering Canadians with trustworthy guidance and the highest-quality natural health products.”Title

Nature’s Source Celebrates 27 Years Empowering Canadian Wellness